BioLASCO Taiwan Co., Ltd. (6662.TWO)
TWD 34.3
(-1.44%)
TWD 34.3
(-1.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 29.45 Million | 44.68 Million | 70.84 Million | 73.53 Million | - |
| Net Income | 61.99 Million | 53.13 Million | 56.44 Million | 78.5 Million | - |
| Depreciation & Amortization | 10.56 Million | 9.96 Million | 9.98 Million | 9.58 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 3.53 Million |
| Change in working capital | -25.06 Million | -2.89 Million | 15.46 Million | 684 Thousand | - |
| Other non-cash items | -537 Thousand | 351 Thousand | 407 Thousand | 202 Thousand | - |
| Investing Cash Flow | -8.83 Million | -28.72 Million | -13.17 Million | -131.26 Million | - |
| Investments in PPE | -1.63 Million | -4.27 Million | -4.35 Million | -114.42 Million | - |
| Acquisitions | - | - | - | -6.03 Million | - |
| Investment purchases | -6.75 Million | -22.29 Million | -12 Million | -11.94 Million | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -452 Thousand | -2.15 Million | 3.18 Million | 967 Thousand | - |
| Financing Cash Flow | -46.15 Million | -48.63 Million | -57.96 Million | 12.34 Million | - |
| Debt repayment | -5.33 Million | -5.33 Million | -4.97 Million | -62.91 Million | - |
| Dividends payments | -38.41 Million | -40.98 Million | -51.22 Million | -48.66 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 106.52 Million |
| Other Financing Activities | -2.4 Million | - | - | - | - |
| Accounts receivables | -18.1 Million | - | - | - | - |
| Accounts payables | -2.94 Million | - | - | - | - |
| Inventory | -10.51 Million | -3.67 Million | 2.93 Million | 12.99 Million | - |
| Other working capital | 3.55 Million | - | - | - | - |
| Cash at beginning of period | 168.5 Million | 201.16 Million | 201.46 Million | 246.84 Million | - |
| Cash at end of period | 142.96 Million | 168.5 Million | 201.16 Million | 201.46 Million | - |
| Capital Expenditure | -1.63 Million | -4.27 Million | -4.35 Million | -114.42 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -25.53 Million | -32.66 Million | -299 Thousand | -45.38 Million | - |
| Free Cash Flow | 27.82 Million | 40.41 Million | 66.48 Million | -40.88 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.34 Million | 4.4 Million | 61.99 Million | 22.07 Million | 14.02 Million | 17.31 Million |
| Depreciation & Amortization | 2.65 Million | 2.66 Million | 10.56 Million | 2.66 Million | 2.68 Million | 2.69 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.73 Million | -14.21 Million | -25.06 Million | -436 Thousand | 8.2 Million | -4.08 Million |
| Other non-cash items | -196 Thousand | 73 Thousand | -537 Thousand | -367 Thousand | -24 Thousand | -265 Thousand |
| Investing Cash Flow | -68.13 Million | -27.48 Million | -8.83 Million | 169 Thousand | -385 Thousand | 63 Thousand |
| Investments in PPE | -49.98 Million | -200 Thousand | -1.63 Million | - | -200 Thousand | -394 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -3000.00 | -27.61 Million | -6.75 Million | - | - | -2000.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -201 Thousand | 325 Thousand | -452 Thousand | 169 Thousand | -185 Thousand | 459 Thousand |
| Financing Cash Flow | 54.03 Million | -1.95 Million | -46.15 Million | -1.94 Million | -39.99 Million | -1.93 Million |
| Debt repayment | -54.66 Million | -1.33 Million | -5.33 Million | -1.33 Million | -972 Thousand | -1.33 Million |
| Dividends payments | - | - | -38.41 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 56 Million | - | - | - | - | - |
| Accounts receivables | -24.2 Million | - | - | - | - | - |
| Accounts payables | 157 Thousand | - | - | - | - | - |
| Inventory | 21.82 Million | -12.87 Million | -10.51 Million | -7.23 Million | -5.64 Million | 3.91 Million |
| Other working capital | 5.52 Million | - | - | - | - | - |
| Cash at beginning of period | 106.06 Million | 142.96 Million | 168.5 Million | 123.07 Million | 140.33 Million | 138.47 Million |
| Cash at end of period | 92.95 Million | 106.06 Million | 142.96 Million | 142.96 Million | 123.07 Million | 140.33 Million |
| Capital Expenditure | -49.98 Million | -200 Thousand | -1.63 Million | - | -200 Thousand | -394 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -13.1 Million | -36.9 Million | -25.53 Million | 19.89 Million | -17.26 Million | 1.85 Million |
| Free Cash Flow | -48.99 Million | -7.67 Million | 27.82 Million | 21.66 Million | 22.92 Million | 3.33 Million |
ALEC
USMT
6752
0148
TNCAF
603803